Page last updated: 2024-08-22

chromium and Carcinoma, Papillary

chromium has been researched along with Carcinoma, Papillary in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clarke, NW; Dangoor, A; Gilham, DE; Griffiths, RW; Hawkins, RE; Ramani, V; Stern, PL	1
Bandy, LC; Clarke-Pearson, DL; Creasman, WT; Soper, JT; Wilkinson, RH	1

Other Studies

2 other study(ies) available for chromium and Carcinoma, Papillary

Article	Year
Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy. British journal of cancer, 2005, Sep-19, Volume: 93, Issue:6 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antibodies, Monoclonal; Antigens, Neoplasm; Apoptosis; Carcinoma, Papillary; Carcinoma, Renal Cell; Chromium; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunotherapy; Interferon-gamma; Kidney Neoplasms; Male; Membrane Glycoproteins; Middle Aged; T-Lymphocytes	2005
Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging. American journal of obstetrics and gynecology, 1987, Volume: 156, Issue:5 Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Papillary; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Reoperation	1987

Article

Year

Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy.

British journal of cancer, 2005, Sep-19, Volume: 93, Issue:6

Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antibodies, Monoclonal; Antigens, Neoplasm; Apoptosis; Carcinoma, Papillary; Carcinoma, Renal Cell; Chromium; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunotherapy; Interferon-gamma; Kidney Neoplasms; Male; Membrane Glycoproteins; Middle Aged; T-Lymphocytes

2005

Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging.

American journal of obstetrics and gynecology, 1987, Volume: 156, Issue:5

Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Papillary; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes; Reoperation

1987